Open en bloc chest wall resection including three ribs and the right lower lobe for T3 lung cancer

ASVIDE ◽  
2020 ◽  
Vol 7 ◽  
pp. 24-24
Author(s):  
Dany Balke ◽  
Varun Gupta ◽  
Stefan Welter
Keyword(s):  
Lung Cancer ◽  
Chest Wall ◽  
Lower Lobe ◽  
Chest Wall Resection ◽  
En Bloc ◽  
The Right

scholarly journals Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2

2020 ◽  
Vol 58 (3) ◽  
pp. 598-604
Author(s):  
Alessandro Gonfiotti ◽  
Lavinia Gatteschi ◽  
Alberto Salvicchi ◽  
Stefano Bongiolatti ◽  
Federico Lavorini ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Severe Acute Respiratory Syndrome ◽  
Chest Wall ◽  
Clinical Data ◽  
Primary Lung Cancer ◽  
Lung Cancer Surgery ◽  
Chest Wall Resection ◽  
Chest Drain ◽  
En Bloc ◽  
Patient Reported

Abstract OBJECTIVES There is currently a lack of clinical data on the novel beta-coronavirus infection [caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] and concomitant primary lung cancer. Our goal was to report our experiences with 5 patients treated for lung cancer while infected with SARS-CoV-2. METHODS We retrospectively evaluated 5 adult patients infected with SARS-CoV-2 who were admitted to our thoracic surgery unit between 29 January 2020 and 4 March 2020 for surgical treatment of a primary lung cancer. Clinical data and outcomes are reported. RESULTS All patients were men with a mean age of 74.0 years (range 67–80). Four of the 5 patients (80%) reported chronic comorbidities. Surgery comprised minimally invasive lobectomy (2 patients) and segmentectomy (1 patient), lobectomy with en bloc chest wall resection (1 patient) and pneumonectomy (1 patient). Mean chest drain duration was 12.4 days (range 8–22); mean hospital stay was 33.8 days (range 21–60). SARS-CoV-2-related symptoms were fever (3 patients), persistent cough (3 patients), diarrhoea (2 patients) and syncope (2 patients); 1 patient reported no symptoms. Morbidity related to surgery was 60%; 30-day mortality was 40%. Two patients (1 with a right pneumonectomy, 74 years old; 1 with a lobectomy with chest wall resection and reconstruction, 70 years old), developed SARS-CoV-2-related lung failure leading to death 60 and 32 days after surgery, respectively. CONCLUSIONS Lung cancer surgery may represent a high-risk factor for developing a severe case of coronavirus disease 2019, particularly in patients with advanced stages of lung cancer. Additional strategies are needed to reduce the risk of morbidity and mortality from SARS-CoV-2 infection during treatment for lung cancer.

scholarly journals A case of cerebro-spinal fluid fistula to the pleural cavity after en-bloc chest wall resection of lung cancer

2004 ◽  
Vol 18 (1) ◽  
pp. 58-63
Author(s):  
Hiroyuki Ito ◽  
Kenji Inui ◽  
Naoki Goto ◽  
Kazuhiro Sakamoto ◽  
Yoshinori Takanashi
Keyword(s):  
Lung Cancer ◽  
Chest Wall ◽  
Pleural Cavity ◽  
Spinal Fluid ◽  
Chest Wall Resection ◽  
En Bloc ◽  
Fluid Fistula

En bloc chest wall resection for peripheral lung cancer

Lung Cancer ◽  
2000 ◽  
Vol 29 (1) ◽  
pp. 139
Author(s):  
P.P Brega Massone ◽  
C Lequaglie ◽  
B Conti ◽  
B Magnani ◽  
I Cataldo
Keyword(s):  
Lung Cancer ◽  
Chest Wall ◽  
Chest Wall Resection ◽  
En Bloc ◽  
Peripheral Lung Cancer ◽  
Peripheral Lung

En Bloc Chest Wall Resection for Candidal Costochondritis in a Drug Addict

1981 ◽  
Vol 31 (2) ◽  
pp. 182-187 ◽  
Author(s):  
Simon Yap ◽  
Mark M. Ravitch ◽  
Kenneth I. Pataki
Keyword(s):  
Chest Wall ◽  
Drug Addict ◽  
Chest Wall Resection ◽  
En Bloc

Right Lower Lobectomy With Middle Lobe Preservation After Right Upper Lobectomy in Lung Cancer of the Right Lower Lobe

2013 ◽  
Vol 96 (6) ◽  
pp. 2227-2230 ◽  
Author(s):  
Naohiro Taira ◽  
Tsutomu Kawabata ◽  
Atsushi Gabe ◽  
Takaharu Ichi ◽  
Kazuaki Kushi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lower Lobe ◽  
Middle Lobe ◽  
Lower Lobectomy ◽  
The Right ◽  
Middle Lobe Preservation ◽  
Right Lower Lobectomy

Non-Small Cell Lung Cancer with Chest Wall Involvement: Integrated Treatment or Surgery Alone?

2018 ◽  
Vol 67 (04) ◽  
pp. 299-305 ◽  
Author(s):  
Marco Chiappetta ◽  
Dania Nachira ◽  
Maria Teresa Congedo ◽  
Elisa Meacci ◽  
Venanzio Porziella ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Prognostic Factors ◽  
Small Cell Lung Cancer ◽  
Chest Wall ◽  
Adjuvant Radiotherapy ◽  
En Bloc Resection ◽  
Bloc Resection ◽  
Small Cell ◽  
Small Cell Lung ◽  
En Bloc

Background The aim of this study was to identify prognostic factors in patients affected by non-small cell lung cancer (NSCLC) with chest wall (CW) involvement, analyzing different strategies of treatment and surgical approaches. Methods Records of 59 patients affected by NSCLC with CW involvement underwent surgery were retrospectively reviewed, from January 2000 to March 2013. Results Induction therapy was administered to 18 (30.5%) patients while adjuvant treatment to 36 (61.0%). In 36 (61%) patients, lung resection was associated only with a parietal pleural resection while in 23 (39%) with CW en-bloc resection. Overall 5-year survival was 34%. Prognostic factors were evaluated in the 51 (86.4%) completely resected (R0) patients.Five-year survival was 60% in patients undergoing induction therapy followed by surgery and 24% in those who underwent surgery as first treatment (p = 0.11). Five-year survival was better in the neoadjuvant group than that in the surgery group in IIB (T3N0) p-stage (100 vs 28%, p = 0.03), while in the IIIA (T3N1–2,T4N0) p-stage it was of 25 vs 0%, respectively (p = 0.53).No 5-year survival difference was found in case of parietal pleural resection versus CW en-bloc resection (p = 0.27) and in case of only parietal pleural involvement versus soft tissue (p = 0.78).In case of incomplete resection (R1), patients undergoing adjuvant radiotherapy had better 2-year survival than patients untreated: 60% vs 0% (p = 0.025). Conclusions Type of surgical resection and the deep of infiltration of disease do not influence survival in this subset of patients. Integrated treatments seem to be suitable: neoadjuvant therapies ensure a better survival rate than surgery alone in IIB and IIIA patients, instead adjuvant radiotherapy proves a fundamental option in incomplete resections.

scholarly journals A Case of “en bloc” Excision of a Chest Wall Leiomyosarcoma and Closure of the Defect with Non-Cross-Linked Collagen Matrix (Egis®)

2016 ◽  
Vol 9 (3) ◽  
pp. 655-660 ◽  
Author(s):  
Marco Rastrelli ◽  
Saveria Tropea ◽  
Romina Spina ◽  
Alessandra Costa ◽  
Roberto Stramare ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Chest Wall ◽  
Tissue Regeneration ◽  
Soft Tissue Sarcomas ◽  
Surgical Excision ◽  
Smooth Muscle Tumor ◽  
Chest Wall Resection ◽  
En Bloc ◽  
Dermal Matrix ◽  
Treatment Protocols

Sarcomas arising from the chest wall account for less than 20% of all soft tissue sarcomas, and at this site, primitive tumors are the most frequent to occur. Leiomyosarcoma is a malignant smooth muscle tumor and the best outcomes are achieved with wide surgical excision. Although advancements have been made in treatment protocols, leiomyosarcoma remains one of the more difficult soft tissue sarcoma to treat. Currently, general local control is obtained with surgical treatment with wide negative margins. We describe the case of a 50-year-old man who underwent a chest wall resection involving a wide portion of the pectoralis major and minor muscle, the serratus and part of the second, third and fourth ribs of the left side. The full-thickness chest wall defect of 10 × 8 cm was closed using a non-cross-linked acellular dermal matrix (Egis®) placed in two layers, beneath the rib plane and over it. A successful repair was achieved with no incisional herniation and with complete tissue regeneration, allowing natural respiratory movements. No complications were observed in the postoperative course. Biological non-cross-linked matrix, derived from porcine dermis, behaves like a scaffold supporting tissue regeneration; it can be successfully used as an alternative to synthetic mesh for chest wall reconstruction.

Sign in / Sign up

Export Citation Format

Share Document